The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America. Here, she shares some strategies.
NextHealth PHL covers the healthcare industry in Philadelphia and the work of scientists, doctors, and healthcare companies in Cellicon Valley. NextHealth PHL puts a special emphasis on healthcare news in the vibrant cell and gene therapies sector.
The funding from the U.S. Department of Commerce will bring more than $1 million and 100 jobs to the region.
The company’s personalized genetic testing service could help clinicians more accurately diagnose and treat an array of mental health conditions.
With its free summer programs at the Science Center, FirstHand could lead more youth to careers in science.
The clinical trial could advance treatment for people with mild-to-moderate Alzheimer’s disease.
Opertech Bio is working with pharmaceutical companies to improve the taste of everything from children’s cough syrup to toothpaste.
Its latest annual report shows how much it has invested in female, minority, and immigrant founders.
Chris Molineaux, the president of Pennsylvania’s only life sciences trade association, explains how Philadelphia can attract more investors and talent.
InstaMed, now backed by JP Morgan Chase, could become the standard for medical billing and payments.
The industry’s integrity is compromised with each new crisis. Two experts explain how these companies can turn the situation around.
Here’s how the pharma giant is working to ensure safer pregnancies and childbirths for moms in Philly
NeuroFlow’s software enables behavioral health specialists and psychologists to remotely monitor a patient’s mental wellness.
The Bucks County incubator has a new investment fund to “expedite impactful scientific discoveries” in the Philadelphia region.
The Camden Opioid Research Initiative (CORI) is building a first-of-its-kind opioid research biobank.
Philly-based Allevi wants to eventually help scientists print functioning organs, too.
The company’s CEO, Ira Pastor, wants to help humans tap into their regeneration superpowers. But is reviving the brain dead ethical or even possible?